Using Generalized Linear Models to Assess Medical Care Costs

  • David K. Blough
  • Scott D. Ramsey
Article

Abstract

Medical expenditure data typically exhibit certain characteristics that must be accounted for when deriving cost estimates. First, it is common for a small percentage of patients to incur extremely high costs compared to other patients, resulting in a distribution of expenses that is highly skewed to the right. Second, the assumption of homoscedasticity (constant variance) is often violated because expense data exhibit variability that increases as the mean expense increases. In this paper, we describe the use of the generalized linear model for estimating costs, and discuss several advantages that this technique has over traditional methods of cost analysis. We provide an example, applying this technique to the problem of determining an incidence-based estimate of the cost of care for patients with diabetes who suffer a stroke.

general lineal model cost diabetes skewness and heteroscedasticity 

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. D. K. Blough, C. Madden and M. Hornbrook, “Risk Modeling Using Generalized Linear Models.” Journal of Health Economics 18: pp. 153-171, 1999.Google Scholar
  2. D. O. Clark, M. Von Korff, K. Saunders, W.M. Baluch and G.E. Simon, “A Chronic Disease Score with Empirically Derived Weights,” Medical Care 33: pp. 783-795, 1995.Google Scholar
  3. N. Duan, W. G. Manning Jr., C. N. Morris and J. P. Newhouse, “A Comparison of Alternative Models for the Demand for Medical Care,” Journal of Business and Economic Statistics 1: pp. 115-126, 1993.Google Scholar
  4. N. Duan, “Smearing Estimate: A Nonparametric Retransformation Method,” Journal of the American Statistical Association 78: pp. 605-610, 1983.Google Scholar
  5. N. Duan, W. G. Manning Jr., C. N. Morris and J.P. Newhouse. “Choosing Between the Sample-Selection Model and the Multi-part Model,” Journal of Business and Economic Statistics 2: pp. 283-289, 1984.Google Scholar
  6. R. A. Dudley, F. E. Harrell, L. R. Smith, D. B. Mark, R. M. Califf, D. B. Pryor, D. Glower, J. Lipscomb and M. Hlatky. “Comparison of analytic models for estimating the effect of clinical factors on the cost of coronary artery bypass graft surgery.” Journal of Clinical Epidemiology 46: pp. 261-271, 1983.Google Scholar
  7. P. Fenn, A. McGuire, V. Phillips, M. Backhouse and D. Jones. “The analysis of censored treatment cost data in economic evaluation.” Medical Care 33: pp. 851-863, 1995.Google Scholar
  8. S. Greenfield, W. Rogers, M. Mangotich, M. F. Carney and A. R. Tarlov. “Outcomes of patients with hypertension and non-insulin dependent diabetes mellitus treated by different systems and specialities”. Results from the medical outcomes study, 274: pp. 1436-44, 1995.Google Scholar
  9. F. E. Harrell and R. L. Smith. “Use of Cox semiparametric regression model for predicting costs, charges, and length of stay.” Duke University, 1995.Google Scholar
  10. T. J. Hastie and R. J. Tibshirani. Generalized Additive Models, (Chapman and Hall, London), 1990.Google Scholar
  11. J. W. Hay and R. J. Olsen. “Let Them Eat Cake: A Note on Comparing Alternative Models of the Demand for Medical Care,” Journal of Business and Economic Statistics 2: pp. 279-282, 1984.Google Scholar
  12. G. Kleinbaum, L. L. Kupper and H. Morgenstern. Epidemiologic Research, (Van Nostrand Reinhold, New York), 1982.Google Scholar
  13. W. G. Manning. “The logged dependent variable, heteroscedasticity, and the retransformation problem,” Journal of Health Economics 17: pp. 283-295, 1998.Google Scholar
  14. P. McCullagh, J. A. Nelder. Generalized Linear Models, (2nd ed.) (Chapman and Hall, London), 1989.Google Scholar
  15. J. Mullahy. “Much ado about two: reconsidering retransformation and the two-part model in health economics,” Journal of Health Economics 17: pp. 247-281, 1998.Google Scholar
  16. S. Ramsey, K. Newton, D. Blough, D. McCulloch, N. Sandhu and E. Wagner. “Patient-Level Estimates of the Cost of Complications in Diabetes in a Managed Care Population.” Pharmacoeconomics 16: pp. 285-295, 1999.Google Scholar
  17. N. Rice and A. Jones. “Multilevel models and health economics.” Health Economics; 6: pp. 561-575, 1997.Google Scholar
  18. SAS/STAT Software: Changes and Enhancements through Release 6.12 (SAS Institute, Cary, North Carolina), 1997.Google Scholar

Copyright information

© Kluwer Academic Publishers 2000

Authors and Affiliations

  • David K. Blough
    • 1
  • Scott D. Ramsey
    • 2
  1. 1.Department of PharmacyUniversity of WashingtonSeattle
  2. 2.Departments of Medicine and Health ServicesUniversity of WashingtonSeattle

Personalised recommendations